Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation

European Respiratory Journal

Volumn 5, Issue 4, 1992, Pages 424-429

  Morrison, J F J ^a   Jones, P C ^a   Muers, M F ^a  

^a Killingbeck Hospital   (United Kingdom)

Author keywords

Bronchodilatation; Chronic obstructive pulmonary disease (COPD); Nebulizer

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; IPRATROPIUM BROMIDE; PLACEBO; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL;

AGED; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; FENOTEROL; HOME CARE SERVICES; HUMAN; IPRATROPIUM; LUNG DISEASES, OBSTRUCTIVE; MALE; NEBULIZERS AND VAPORIZERS; PREDNISOLONE; RESPIRATORY FUNCTION TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026506790     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)